neurotransmitter | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

214 results for “neurotransmitter”

Neurocosmetics: The Emerging Science of Skin-Nervous System Communication in Dermatology

IBD Patients Face Elevated Risk of Depression and Anxiety Through Gut-Brain Axis Dysfunction

Neuro-Immune Interactions in Cancer: Emerging Therapeutic Strategies Target the Neural Addiction of Tumors

Luye Pharma's Novel Antidepressant LY03021 Approved for Clinical Trials in China

Novel NMDA Inhibitor AXS-05 Shows Promise for Alzheimer's Agitation Without Antipsychotic Risks

FDA Approves Kebilidi, First Gene Therapy for AADC Deficiency

Cobenfy Approved for Schizophrenia: A Novel Muscarinic Receptor Agonist

Infant Thriving After Gene Therapy for AADC Deficiency Following FDA Approval of KEBILIDI™

Energenesis Biomedical Advances First-in-Class Parkinson's Disease Therapy ENERGI-F705PD Toward Phase I Data Readout

ConSynance Therapeutics Receives FDA Rare Pediatric Disease Designation for CSTI-500 in Prader-Willi Syndrome

Page 1 of 18